Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: Is 6 months still appropriate?

Title
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: Is 6 months still appropriate?
Authors
Keywords
-
Journal
REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 50, Issue 1, Pages 2-22
Publisher
Elsevier BV
Online
2007-08-27
DOI
10.1016/j.yrtph.2007.08.001

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search